( for over250000 people in the US annu...)Hypertension Education Foundation Survey Results Announced At,American Society For Hypertension Annual Meeting Suggests Improved,Control Of High Blood Pressure, But Misconceptions Still Exist,Health

for over 250,000 people in the US annually and it is the most common reason that adults see physicians, according to a 2004 report by the U.S. Department of Health and Human Services, National Institutes of Health and National Heart, Lung and, Blood Institute. It is a significant risk factor for coronary heart disease, stroke, and heart and kidney failure. When combined with other conditions, such as an elevated cholesterol level or diabetes, HBP significantly increases chances of a cardiovascular event. The good news, Dr. Moser notes, is that lowering blood pressure (BP) over time will result in decreases of between 35 and 50% in these complications.

The not so good news, according to the survey findings, is that at least one-third (36%) of patients taking medication had BPs higher than 140/90 mm Hg (the present goal for the general public), the last time they had it checked. (An additional 14% were not sure what their BP was the last time they had it checked.) Although this percentage is considerably lower than in previous surveys, half of the respondents (50%) report that they were told by their physician that their blood pressure was too high at some point since they began taking medication. These results cannot be directly compared to previous surveys since they represent respondents' answers and not the results of patient examinations. Approximately one-third (31%) of those who were told that their BP was still too high after they began to take medication were told by their healthcare provider to keep taking the same medication. This finding is consistent with other studies.

The survey, which was supported by a grant from King Pharmaceuticals, Inc., polled 1,245 adults age 45+ who have been diagnosed with HBP. The survey suggests that most people with HBP understand the risks associated with it and recognize what they might have to do to help control it. At least nine out of ten (91%) people surveyed are aware that losing excess weight and regul
'"/>

Page: 1 2 3 4 5 6 7
Related medicine technology :

1. Speedel Reports Successful SPP635 Phase IIa Trial in Hypertension
2. Hypertension Vaccine CYT006-AngQb Achieves Strong Blood Pressure Reduction During Important Early Morning Period When Most Adverse Cardiovascular Events Occur
3. Prexige Study Shows Significantly Less Impact on Blood Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled Hypertension
4. Lumiracoxib Study Showed Significantly Less Impact on Blood Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled Hypertension
5. Amlodipine and Olmesartan Study Results Released;Late Breaker Presented at American Society of Hypertension Twenty-Second Annual Scientific Meeting (ASH 2007)
6. Gilead Announces Presentation of Long-Term Data for Ambrisentan, a Potential Treatment for Patients With Pulmonary Arterial Hypertension
7. New Data Highlights Potential of SPP100 (Tekturna) as Gold Standard Therapy in Treatment of Hypertension
8. Amlodipine and Olmesartan Study Results Released; Late Breaker Presented at American Society of Hypertension Twenty-Second Annual Scientific Meeting (ASH 2007)
9. King Pharmaceuticals Announces Plan to Present Results from Phase III Clinical Trial Evaluating ALTACE as Monotherapy and in Combination with Hydrochlorothiazide at the American Society of Hypertension Annual Meeting
10. Landmark Findings From ECLIPSE Program Show Improved Control of Perioperative Hypertension Reduces Risk of Death In Cardiac Surgery
11. The International Myeloma Foundation Says Data Reported at a Global Medical Meeting in Greece Demonstrates Improved Survival for a Wide Range of Myeloma Patients